Novartis Ag (NVSEF) Asset Utilization Ratio (2009 - 2010)
Novartis Ag's (NVSEF) quarterly Asset Utilization Ratio came in at 0.13 in Q1 2010, down 100.0% year-on-year from 258568778565.36 in Q1 2009, and up 54630111.7% quarter-over-quarter from 0.0 in Q4 2009.
Novartis Ag (NVSEF) Asset Utilization Ratio (2009 - 2010) Analysis & Trends
Novartis Ag has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.13 for Q1 2010.
- Asset Utilization Ratio for Q1 2010 came in at 0.13, down 100.0% year-over-year; the trailing twelve-month figure through Mar 2010 was 0.13 (down 100.0% YoY), and the FY2025 annual result was 0.51, up 2.78% from the prior year.
- Asset Utilization Ratio came in at 0.13 for Q1 2010 at Novartis Ag, up from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 258483772746.46 in Q1 2009 to a low of 0.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 0.53 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.63 |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.48 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.46 |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.12 |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.55 |
| 10 | Novartis Ag | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | 0.13 |
| Dec 31, 2009 | 0.00 |
| Sep 30, 2009 | 115.19 Bn |
| Jun 30, 2009 | 124.22 Bn |
| Mar 31, 2009 | 258.48 Bn |